Project Orbis: new collaborative program allows for concurrent drug approvals in participating countries
Earlier this year, the FDA announced the launch of Project Orbis, a collaborative program which allows for the concurrent submission and review of oncology drugs between partner regulatory agencies. The premise behind such a program [...]